The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 22, 2018
Filed:
Jun. 16, 2017
Applicant:
Menlo Therapeutics Inc., Menlo Park, CA (US);
Inventors:
Xiaoming Zhang, Sunnyvale, CA (US);
Edward F. Schnipper, Redwood City, CA (US);
Andrew J. Perlman, Stanford, CA (US);
James W. Larrick, Sunnyvale, CA (US);
Assignee:
MENLO THERAPEUTICS INC., Redwood City, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/403 (2006.01); A61K 45/06 (2006.01); A61K 9/06 (2006.01); A61K 9/48 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 47/10 (2017.01); A61K 31/4035 (2006.01);
U.S. Cl.
CPC ...
A61K 31/403 (2013.01); A61K 9/0014 (2013.01); A61K 9/0053 (2013.01); A61K 9/06 (2013.01); A61K 9/2054 (2013.01); A61K 9/4858 (2013.01); A61K 9/4883 (2013.01); A61K 31/4035 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01);
Abstract
The invention relates to methods for treating pruritus with NK-1 receptor antagonists such as serlopitant. The invention further relates to pharmaceutical compositions comprising NK-1 receptor antagonists such as serlopitant. In addition, the invention encompasses treatment of a pruritus-associated condition with serlopitant and an additional antipruritic agent, and the use of serlopitant as a sleep aid, optionally in combination with an additional sleep-aiding agent.